Literature DB >> 25020230

Direct interaction of 14-3-3ζ with ezrin promotes cell migration by regulating the formation of membrane ruffle.

Miaojuan Chen1, Tengfei Liu1, Lina Xu1, Xuejuan Gao1, Xiaohui Liu1, Cuihua Wang1, Qingyu He1, Gong Zhang1, Langxia Liu2.   

Abstract

14-3-3 proteins have been shown to regulate the actin cytoskeleton remodeling, cell adhesion and migration. In this study, we identified ezrin, a cross-linker between plasma membrane and actin cytoskeleton, as a novel 14-3-3ζ interacting partner. The direct interaction between 14-3-3ζ and ezrin was validated in the cells and by in vitro assays. We showed that the 14-3-3ζ binding region in ezrin was located within the N-terminal and central α-helical domains and that the αG-to-αI helices of 14-3-3ζ are responsible for the binding to ezrin. Functional analyses revealed that the regulation of cell migration and membrane ruffling by 14-3-3ζ is ezrin dependent, for which the integrity of ezrin protein was required. Conversely, the knockdown of 14-3-3ζ abrogates also the stimulatory effect of ezrin on cell migration and membrane ruffling. Moreover, we found that the phosphorylation of Thr567 in ezrin facilitates the 14-3-3ζ-ezrin interaction and the formation of membrane ruffles. Taken together, these results suggest strongly that the functions of these two proteins in cell migration are linked and might be mediated by their direct physical interaction, which is important for the formation of membrane ruffles.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  14-3-3 zeta; actin cytoskeleton remodeling; cell migration; ezrin; protein–protein interaction

Mesh:

Substances:

Year:  2014        PMID: 25020230     DOI: 10.1016/j.jmb.2014.06.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

Review 1.  14-3-3 proteins in platelet biology and glycoprotein Ib-IX signaling.

Authors:  Yunfeng Chen; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2018-04-05       Impact factor: 22.113

2.  BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors:  David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Posttranscriptional regulation of 14-3-3ζ by RNA-binding protein HuR modulating intestinal epithelial restitution after wounding.

Authors:  Natasha Z Hansraj; Lan Xiao; Jing Wu; Gang Chen; Douglas J Turner; Jian-Ying Wang; Jaladanki N Rao
Journal:  Physiol Rep       Date:  2016-07

4.  The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma.

Authors:  Juan-Feng Zhao; Qiu Zhao; Hui Hu; Jia-Zhi Liao; Ju-Sheng Lin; Chao Xia; Ying Chang; Jing Liu; An-Yuan Guo; Xing-Xing He
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-25       Impact factor: 8.886

5.  14-3-3εa directs the pulsatile transport of basal factors toward the apical domain for lumen growth in tubulogenesis.

Authors:  Yuji Mizotani; Mayu Suzuki; Kohji Hotta; Hidenori Watanabe; Kogiku Shiba; Kazuo Inaba; Etsu Tashiro; Kotaro Oka; Masaya Imoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-29       Impact factor: 11.205

6.  Role of phospho-ezrin in differentiating thyroid carcinoma.

Authors:  Lakshmi Mohan Lathika; Jagathnath Krishna Kumarapillai Mohanan Nair; Valliamma Neelakandapilla Saritha; Kunjuraman Sujathan; Sreeharshan Sreeja
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

7.  Allosteric regulation of protein 14-3-3ζ scaffold by small-molecule editing modulates histone H3 post-translational modifications.

Authors:  Yan-Jun Wan; Li-Xi Liao; Yang Liu; Heng Yang; Xiao-Min Song; Li-Chao Wang; Xiao-Wen Zhang; Yi Qian; Dan Liu; Xiao-Meng Shi; Li-Wen Han; Qing Xia; Ke-Chun Liu; Zhi-Yong Du; Yong Jiang; Ming-Bo Zhao; Ke-Wu Zeng; Peng-Fei Tu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.